ANNE TSAO to Receptor, ErbB-2
This is a "connection" page, showing publications ANNE TSAO has written about Receptor, ErbB-2.
Connection Strength
0.146
-
Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial. J Clin Oncol. 2022 03 01; 40(7):702-709.
Score: 0.094
-
Non-small-cell lung cancer with HER2 exon 20 mutation: regression with dual HER2 inhibition and anti-VEGF combination treatment. J Thorac Oncol. 2013 Feb; 8(2):e19-20.
Score: 0.052